Novo Nordisk’s Oral Wegovy Sales Surprise Caps Strong Data Showing at Istanbul Obesity Congress
Novo Nordisk’s oral Wegovy rakes in 2.26B kroner in first quarter, nearly double consensus; high-dose injectable shows 27.7%…
Novo Nordisk’s Dividend Yield Nears 5% as Washington Shuffle and Medicare Price Caps Reshape the G
Novo Nordisk’s stock slide pushes dividend yield toward 5%, but pricing pressure and a Washington lobbying pivot signal…